Dan Xie

24.7k citations

356 papers · 16.3k · 3 hit papers · h-index 70

Impact in

Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 0.2%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA Research and Splicing

Papers in

Molecular Biology 182
- RNA modifications and cancer 42
- Epigenetics and DNA Methylation 34
- Cancer-related gene regulation 29
- Circular RNAs in diseases 26
- RNA Research and Splicing 18
- Ubiquitin and proteasome pathways 14
Oncology 69

Co-authors: Xin‐Yuan Guan (95 shared papers)Rui‐Hua Xu (27 shared papers)Huai‐Qiang Ju (13 shared papers)Yi-Xin Zeng (27 shared papers)Hsiang‐Fu Kung (29 shared papers)Mu-Yan Cai (29 shared papers)Jiaxing Zhang (17 shared papers)Liang Hu (19 shared papers)
Journals: Cancer Research (15 papers)Oncotarget (14 papers)Cancer Letters (13 papers)Oncogene (12 papers)Cell Death and Disease (10 papers)
Partner nations: China Hong Kong United States

In The Last Decade

Dan Xie

348 papers receiving 16.2k citations

Dan Xie's Hit Papers

align trajectories log scale

NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications 2020 · 404 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Signal Transduction and Targeted Therapy
2019 Molecular Cancer
2019 Nature Communications

Peers

Countries citing papers authored by Dan Xie

Since Specialization

Citations

This map shows the geographic impact of Dan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Xie more than expected).

Fields of papers citing papers by Dan Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Xie. The network helps show where Dan Xie may publish in the future.

Co-authors

The 25 scholars most cited alongside Dan Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dan Xie Line = papers co-authored together Dan Xie links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 356 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma Molecular Cancer ·Ting Li, Pei-Shan Hu, Zhixiang Zuo, Jin-Fei Lin, Xingyang Li, Qi-Nian Wu, Zhan‐Hong Chen, Zhao-Lei Zeng, Feng Wang, Jian Zheng, Demeng Chen, Bo Li, Tiebang Kang, Dan Xie, Dongxin Lin, Huai‐Qiang Ju, Rui‐Hua Xu Hit paper breakdown →	2019	614
2	N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Nature Communications ·Rixin Chen, Xin Chen, Liangping Xia, Jiaxing Zhang, Zhizhong Pan, Xiaodan Ma, Kai Han, Jiewei Chen, Jean-Gabrie Judde, Olivier Déas, Feng Wang, Ning‐Fang Ma, Xin‐Yuan Guan, Jing‐Ping Yun, Feng‐Wei Wang, Rui‐Hua Xu, Dan Xie Hit paper breakdown →	2019	548
3	Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis The Lancet Oncology ·Jiaxing Zhang, Song Wu, Zhenhua Chen, Jinhuan Wei, Yi-Ji Liao, Jian Lei, Ming Hu, Geng-Zhen Chen, Bing Liao, Jian Lü, Hong-Wei Zhao, Wei Chen, Yu-Long He, Hui‐Yun Wang, Dan Xie, Junhang Luo	2013	452
4	NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications Signal Transduction and Targeted Therapy ·Huai‐Qiang Ju, Jin‐Fei Lin, Tian Tian, Dan Xie, Rui‐Hua Xu Hit paper breakdown →	2020	404
5	PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial–Mesenchymal Transition Clinical Cancer Research ·Xin Chen, Ri-Xin Chen, Wen-Su Wei, Frank Yonghong Li, Zi-Hao Feng, Lei Tan, Jie-Wei Chen, Gang-Jun Yuan, Si-Liang Chen, Shengjie Guo, Kang-Hua Xiao, Zhuowei Liu, Junhang Luo, Fangjian Zhou, Dan Xie	2018	288
6	LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization Cell Death and Disease ·Zhenxing Liang, Huashan Liu, Fengwei Wang, Li Xiong, Chi Zhou, Tuo Hu, Xiaowen He, Xiaojian Wu, Dan Xie, Xianrui Wu, Ping Lan	2019	271
7	Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression Theranostics ·Dong-liang Chen, Yun-Xin Lu, Jiaxing Zhang, Xiao-Li Wei, Feng Wang, Zhao-Lei Zeng, Zhi-Zhong Pan, Yunfei Yuan, Feng-Hua Wang, Hélène Pelicano, Paul J. Chiao, Peng Huang, Dan Xie, Yuhong Li, Huai‐Qiang Ju, Rui‐Hua Xu	2017	247
8	Increased Intratumoral Neutrophil in Colorectal Carcinomas Correlates Closely with Malignant Phenotype and Predicts Patients' Adverse Prognosis PLoS ONE ·Hui-Lan Rao, Jie-Wei Chen, Mei Li, Yong-Bo Xiao, Jia Fu, Yi Zeng, Mu Yan Cai, Dan Xie	2012	231
9	Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression Journal of Experimental & Clinical Cancer Research ·Dongliang Chen, Huai‐Qiang Ju, Yun‐Xin Lu, Lezong Chen, Zhao-Lei Zeng, Dongsheng Zhang, Hui Luo, Feng Wang, Miao‐Zhen Qiu, De‐Shen Wang, Dazhi Xu, (unknown), Hélène Pelicano, Peng Huang, Dan Xie, Feng‐Hua Wang, Yuhong Li, Rui‐Hua Xu	2016	217
10	Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis Theranostics ·Xiao-Peng Tian, Chen-Yuan Wang, Xiao-Han Jin, Mei Li, Feng-Wei Wang, Wei-Juan Huang, Jing‐Ping Yun, Rui‐Hua Xu, Qing-Qing Cai, Dan Xie	2019	199
11	Correction: LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization Cell Death and Disease ·Zhenxing Liang, Huashan Liu, Feng‐Wei Wang, Li Xiong, Chi Zhou, Tuo Hu, Xiaowen He, Xiaojian Wu, Dan Xie, Xianrui Wu, Ping Lan	2020	197
12	Association of Vimentin overexpression and hepatocellular carcinoma metastasis Oncogene ·Liang Hu, Sze Hang Lau, Chi‐Hung Tzang, Jian‐Ming Wen, Weisheng Wang, Dan Xie, Minghui Huang, Yi Wang, Meng‐Chao Wu, Jie-Fu Huang, Wei-Fen Zeng, Jonathan S. T. Sham, Mengsu Yang, Xin‐Yuan Guan	2003	194
13	EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin Oncogene ·Z-T Tong, M-Y Cai, (unknown), L-L Kong, S-J Mai, Y-H Liu, H. B. Zhang, (unknown), Fei-Meng Zheng, Wei‐Guo Zhu, (unknown), X‐W Bian, (unknown), M C Lin, (unknown), Y-X Zeng, H-F Kung, Dan Xie	2011	177
14	Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma Journal of Translational Medicine ·Yuhong Li, Chun-Fang Hu, Qiong Shao, Ma-Yan Huang, Jing-Hui Hou, Dan Xie, Yi-Xin Zeng, Jian‐Yong Shao	2008	160
15	High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients British Journal of Cancer ·(unknown), Yi‐Long Wu, X-N Yang, W-Z. Zhong, Dan Xie, (unknown), Dorothea Fischer, H-C Kolberg, Sandra Krüger, H-W Stuerzbecher	2005	149
16	Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial–mesenchymaltransition Gut ·Wei Zhu, Mu-Yan Cai, Zhu‐Ting Tong, Sui-Sui Dong, Shi-Juan Mai, (unknown), Xiu‐Wu Bian, Marie C. Lin, Hsiang‐Fu Kung, Yi-Xin Zeng, Xin‐Yuan Guan, Dan Xie	2011	147
17	METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition Gynecologic Oncology ·Wenfeng Hua, Yuan Zhao, Xiaohan Jin, Danyang Yu, Jing He, Dan Xie, Ping Duan	2018	146
18	Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer Gut ·De‐Shen Wang, Zexian Liu, Yun-Xin Lu, Hua Bao, Xue Wu, Zhao-Lei Zeng, Zekun Liu, Qi Zhao, Cai-Yun He, Jia-Huan Lu, Zhiqiang Wang, Miao‐Zhen Qiu, Feng Wang, Feng‐Hua Wang, Yu-Hong Li, Xiao-Nan Wang, Dan Xie, Wei-Hua Jia, Yang Shao, Rui‐Hua Xu	2018	143
19	Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications JNCI Journal of the National Cancer Institute ·Huai‐Qiang Ju, Yun-Xin Lu, Dong-liang Chen, Zhi-Xiang Zuo, Zexian Liu, Qi-Nian Wu, Hai-Yu Mo, Zixian Wang, De‐Shen Wang, Heng‐Ying Pu, Zhao-Lei Zeng, Bo Li, Dan Xie, Peng Huang, Mien‐Chie Hung, Paul J. Chiao, Rui‐Hua Xu	2018	142
20	EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies Gut ·Muyan Cai, Zhichao Tong, (unknown), (unknown), Yiqin Wang, Hui Rao, Yangchao Chen, Qi‐Nian Wu, Y.-H. Liu, Xin‐Yuan Guan, M C Lin, Yi‐Xin Zeng, (unknown), Dan Xie	2011	138

About Dan Xie

Dan Xie is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Cell Biology, having authored 356 papers that have together received 16.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (42 papers), Epigenetics and DNA Methylation (34 papers), Cancer-related gene regulation (29 papers), Cancer-related molecular mechanisms research (28 papers), MicroRNA in disease regulation (27 papers), Circular RNAs in diseases (26 papers), RNA Research and Splicing (18 papers) and Ubiquitin and proteasome pathways (14 papers). The work is most often cited by research in Cancer Research (5.4k citations), Molecular Biology (9.9k citations), Oncology (2.9k citations), Immunology (1.3k citations) and Hepatology (413 citations). Dan Xie has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xin‐Yuan Guan, Rui‐Hua Xu, Huai‐Qiang Ju, Yi-Xin Zeng, Hsiang‐Fu Kung, Mu-Yan Cai, Jiaxing Zhang, Liang Hu, Zhao-Lei Zeng and Yi-Ji Liao. Their work appears in journals such as Cancer Research, Oncotarget, Cancer Letters, Oncogene and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Dan Xie

Impact in

Papers in i

In The Last Decade

Dan Xie

Dan Xie's Hit Papers

Peers

Countries citing papers authored by Dan Xie

Fields of papers citing papers by Dan Xie

All Works

About Dan Xie

Explore authors with similar magnitude of impact

Papers in